Loading organizations...
Based in Mannheim, Germany, faCellitate develops patented polymeric surface coatings for plastic and glassware to enable advanced 3D cell culture applications in drug discovery and fundamental research. The flagship product of the company is BIOFLOAT, an anti-adhesive 96-well plate designed for rapid spheroid production in modern laboratory environments. Originally developed as an internal research project within BASF, the enterprise spun out of the Chemovator incubation program in late 2021 under the leadership of cofounder Simon Widmaier. The startup has successfully raised three million seven hundred thousand euros in seed funding to date, securing capital from a syndicate of institutional and strategic investors including SARSTEDT, ARVE Capital, and High-Tech Gründerfonds. The growing firm primarily serves life sciences laboratories, biotechnology companies, and academic research institutions requiring specialized in vitro cell culture models for their drug development pipelines.
faCellitate has raised $3.7M across 1 funding round.
faCellitate has raised $3.7M in total across 1 funding round.
faCellitate has raised $3.7M across 1 funding round. Most recently, it raised $3.7M Seed in September 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 7, 2022 | $3.7M Seed | Angelika Vlachou, Timo Schretzmair | Arve Capital, Chemovator, R3 Consulting, ROI Verwaltungsgesellschaft | Announced |
faCellitate has raised $3.7M in total across 1 funding round.
faCellitate's investors include Angelika Vlachou, Timo Schretzmair, Arve Capital, Chemovator, R3 Consulting, ROI Verwaltungsgesellschaft.
